In vitro chemosensitivity testing in acute non lymphocytic leukemia using the bioluminescence ATP assay
The ATP assay is a short term in vitro chemosensitivity assay where the amount of viable cells are determined by their content of ATP. The aim of the study was to compare the in vitro results of six cytostatic drugs to the clinical outcome in 83 acute non-lymphocytic leukemia (ANLL) patients. The se...
Gespeichert in:
| Veröffentlicht in: | Leukemia research 2000-05, Vol.24 (5), p.445-452 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 452 |
|---|---|
| container_issue | 5 |
| container_start_page | 445 |
| container_title | Leukemia research |
| container_volume | 24 |
| creator | Möllgård, Lars Tidefelt, Ulf Sundman-Engberg, Britt Löfgren, Christina Paul, Christer |
| description | The ATP assay is a short term in vitro chemosensitivity assay where the amount of viable cells are determined by their content of ATP. The aim of the study was to compare the in vitro results of six cytostatic drugs to the clinical outcome in 83 acute non-lymphocytic leukemia (ANLL) patients. The secondary ANLL at diagnosis showed an in vitro resistance to daunorubicin that was significantly higher compared to de novo ANLL at diagnosis (
P |
| doi_str_mv | 10.1016/S0145-2126(00)00003-5 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_601999</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0145212600000035</els_id><sourcerecordid>71064623</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-cc55084e826b51c0ed019a9293ed931f37157944e61f8bd85b3a3023734e883c3</originalsourceid><addsrcrecordid>eNqFkUtPxCAUhYnR6Pj4CRpWRhdVKKUtKzMxvhITTRzXhNI7M2gLY6Ga_nsZOzHuZMPNzXfuhXMQOqbkghKaX74QmvEkpWl-Rsg5iYclfAtNaFnEomR8G01-kT207_1bZLigYhftUVKUPM2LCVo8WPxpQuewXkLrPFhvgomdAQfwwdgFNhYr3QfA1lncDO1q6fQQjMYN9O_QGoV7v-bCEnBlXNO3xoLXYDXg6ewZK-_VcIh25qrxcLS5D9Dr7c3s-j55fLp7uJ4-JpoJERKtOSdlBmWaV5xqAjWhQolUMKgFo3NWUF6ILIOczsuqLnnFFCMpK1jUlEyzA5SMc_0XrPpKrjrTqm6QThm5ab3HCmQeBwsR-dORX3Xuo48_lq2Jb28aZcH1XhaU5FmesgjyEdSd876D-e9oSuQ6EfmTiFzbLQmRP4lIHnUnmwV91UL9RzVGEIGrEYBoy6eBTnpt1ubVpgMdZO3MPyu-AXw8nBY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71064623</pqid></control><display><type>article</type><title>In vitro chemosensitivity testing in acute non lymphocytic leukemia using the bioluminescence ATP assay</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Möllgård, Lars ; Tidefelt, Ulf ; Sundman-Engberg, Britt ; Löfgren, Christina ; Paul, Christer</creator><creatorcontrib>Möllgård, Lars ; Tidefelt, Ulf ; Sundman-Engberg, Britt ; Löfgren, Christina ; Paul, Christer</creatorcontrib><description>The ATP assay is a short term in vitro chemosensitivity assay where the amount of viable cells are determined by their content of ATP. The aim of the study was to compare the in vitro results of six cytostatic drugs to the clinical outcome in 83 acute non-lymphocytic leukemia (ANLL) patients. The secondary ANLL at diagnosis showed an in vitro resistance to daunorubicin that was significantly higher compared to de novo ANLL at diagnosis (
P<0.003). De novo ANLL at diagnosis that achieved complete remission (CR) were significantly more sensitive to daunorubicin compared to those who didn’t achieve CR (
P<0.05). There was an vitro correlation between topoisomerase II active drugs but not between these drugs and ara-C. In vitro ara-C sensitivity (≤ the median of the de novo ANLL at diagnosis) was correlated to poor overall survival (
P=0.02). In vitro sensitivity to daunorubicin and mitoxantrone was associated with prolonged disease free survival (
P=0.03 and
P=0.04). We conclude that despite significant correlation to clinical parameters for daunorubicin and mitoxantrone the predictive value of the ATP assay in this material was insufficient for directing therapy.</description><identifier>ISSN: 0145-2126</identifier><identifier>EISSN: 1873-5835</identifier><identifier>DOI: 10.1016/S0145-2126(00)00003-5</identifier><identifier>PMID: 10785267</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Acute Disease ; Adenosine Triphosphate - analysis ; Antibiotics, Antineoplastic - pharmacology ; Antibiotics, Antineoplastic - therapeutic use ; Biological Assay ; Bioluminiscence ATP assay ; Cell Survival ; Chemosensitivity ; Cytotoxicity ; Daunorubicin - pharmacology ; Daunorubicin - therapeutic use ; Drug resistance ; Drug Resistance, Microbial ; Drug Resistance, Neoplasm ; Humans ; Leukemia, Myeloid - drug therapy ; Leukemia, Myeloid - metabolism ; Leukemia, Myeloid - pathology ; Luminescent Measurements ; Myeloid leukemia ; Sensitivity and Specificity ; Tumor Cells, Cultured</subject><ispartof>Leukemia research, 2000-05, Vol.24 (5), p.445-452</ispartof><rights>2000 Elsevier Science Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-cc55084e826b51c0ed019a9293ed931f37157944e61f8bd85b3a3023734e883c3</citedby><cites>FETCH-LOGICAL-c399t-cc55084e826b51c0ed019a9293ed931f37157944e61f8bd85b3a3023734e883c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0145-2126(00)00003-5$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10785267$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:1942043$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Möllgård, Lars</creatorcontrib><creatorcontrib>Tidefelt, Ulf</creatorcontrib><creatorcontrib>Sundman-Engberg, Britt</creatorcontrib><creatorcontrib>Löfgren, Christina</creatorcontrib><creatorcontrib>Paul, Christer</creatorcontrib><title>In vitro chemosensitivity testing in acute non lymphocytic leukemia using the bioluminescence ATP assay</title><title>Leukemia research</title><addtitle>Leuk Res</addtitle><description>The ATP assay is a short term in vitro chemosensitivity assay where the amount of viable cells are determined by their content of ATP. The aim of the study was to compare the in vitro results of six cytostatic drugs to the clinical outcome in 83 acute non-lymphocytic leukemia (ANLL) patients. The secondary ANLL at diagnosis showed an in vitro resistance to daunorubicin that was significantly higher compared to de novo ANLL at diagnosis (
P<0.003). De novo ANLL at diagnosis that achieved complete remission (CR) were significantly more sensitive to daunorubicin compared to those who didn’t achieve CR (
P<0.05). There was an vitro correlation between topoisomerase II active drugs but not between these drugs and ara-C. In vitro ara-C sensitivity (≤ the median of the de novo ANLL at diagnosis) was correlated to poor overall survival (
P=0.02). In vitro sensitivity to daunorubicin and mitoxantrone was associated with prolonged disease free survival (
P=0.03 and
P=0.04). We conclude that despite significant correlation to clinical parameters for daunorubicin and mitoxantrone the predictive value of the ATP assay in this material was insufficient for directing therapy.</description><subject>Acute Disease</subject><subject>Adenosine Triphosphate - analysis</subject><subject>Antibiotics, Antineoplastic - pharmacology</subject><subject>Antibiotics, Antineoplastic - therapeutic use</subject><subject>Biological Assay</subject><subject>Bioluminiscence ATP assay</subject><subject>Cell Survival</subject><subject>Chemosensitivity</subject><subject>Cytotoxicity</subject><subject>Daunorubicin - pharmacology</subject><subject>Daunorubicin - therapeutic use</subject><subject>Drug resistance</subject><subject>Drug Resistance, Microbial</subject><subject>Drug Resistance, Neoplasm</subject><subject>Humans</subject><subject>Leukemia, Myeloid - drug therapy</subject><subject>Leukemia, Myeloid - metabolism</subject><subject>Leukemia, Myeloid - pathology</subject><subject>Luminescent Measurements</subject><subject>Myeloid leukemia</subject><subject>Sensitivity and Specificity</subject><subject>Tumor Cells, Cultured</subject><issn>0145-2126</issn><issn>1873-5835</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtPxCAUhYnR6Pj4CRpWRhdVKKUtKzMxvhITTRzXhNI7M2gLY6Ga_nsZOzHuZMPNzXfuhXMQOqbkghKaX74QmvEkpWl-Rsg5iYclfAtNaFnEomR8G01-kT207_1bZLigYhftUVKUPM2LCVo8WPxpQuewXkLrPFhvgomdAQfwwdgFNhYr3QfA1lncDO1q6fQQjMYN9O_QGoV7v-bCEnBlXNO3xoLXYDXg6ewZK-_VcIh25qrxcLS5D9Dr7c3s-j55fLp7uJ4-JpoJERKtOSdlBmWaV5xqAjWhQolUMKgFo3NWUF6ILIOczsuqLnnFFCMpK1jUlEyzA5SMc_0XrPpKrjrTqm6QThm5ab3HCmQeBwsR-dORX3Xuo48_lq2Jb28aZcH1XhaU5FmesgjyEdSd876D-e9oSuQ6EfmTiFzbLQmRP4lIHnUnmwV91UL9RzVGEIGrEYBoy6eBTnpt1ubVpgMdZO3MPyu-AXw8nBY</recordid><startdate>20000501</startdate><enddate>20000501</enddate><creator>Möllgård, Lars</creator><creator>Tidefelt, Ulf</creator><creator>Sundman-Engberg, Britt</creator><creator>Löfgren, Christina</creator><creator>Paul, Christer</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope></search><sort><creationdate>20000501</creationdate><title>In vitro chemosensitivity testing in acute non lymphocytic leukemia using the bioluminescence ATP assay</title><author>Möllgård, Lars ; Tidefelt, Ulf ; Sundman-Engberg, Britt ; Löfgren, Christina ; Paul, Christer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-cc55084e826b51c0ed019a9293ed931f37157944e61f8bd85b3a3023734e883c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Acute Disease</topic><topic>Adenosine Triphosphate - analysis</topic><topic>Antibiotics, Antineoplastic - pharmacology</topic><topic>Antibiotics, Antineoplastic - therapeutic use</topic><topic>Biological Assay</topic><topic>Bioluminiscence ATP assay</topic><topic>Cell Survival</topic><topic>Chemosensitivity</topic><topic>Cytotoxicity</topic><topic>Daunorubicin - pharmacology</topic><topic>Daunorubicin - therapeutic use</topic><topic>Drug resistance</topic><topic>Drug Resistance, Microbial</topic><topic>Drug Resistance, Neoplasm</topic><topic>Humans</topic><topic>Leukemia, Myeloid - drug therapy</topic><topic>Leukemia, Myeloid - metabolism</topic><topic>Leukemia, Myeloid - pathology</topic><topic>Luminescent Measurements</topic><topic>Myeloid leukemia</topic><topic>Sensitivity and Specificity</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Möllgård, Lars</creatorcontrib><creatorcontrib>Tidefelt, Ulf</creatorcontrib><creatorcontrib>Sundman-Engberg, Britt</creatorcontrib><creatorcontrib>Löfgren, Christina</creatorcontrib><creatorcontrib>Paul, Christer</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>Leukemia research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Möllgård, Lars</au><au>Tidefelt, Ulf</au><au>Sundman-Engberg, Britt</au><au>Löfgren, Christina</au><au>Paul, Christer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro chemosensitivity testing in acute non lymphocytic leukemia using the bioluminescence ATP assay</atitle><jtitle>Leukemia research</jtitle><addtitle>Leuk Res</addtitle><date>2000-05-01</date><risdate>2000</risdate><volume>24</volume><issue>5</issue><spage>445</spage><epage>452</epage><pages>445-452</pages><issn>0145-2126</issn><eissn>1873-5835</eissn><abstract>The ATP assay is a short term in vitro chemosensitivity assay where the amount of viable cells are determined by their content of ATP. The aim of the study was to compare the in vitro results of six cytostatic drugs to the clinical outcome in 83 acute non-lymphocytic leukemia (ANLL) patients. The secondary ANLL at diagnosis showed an in vitro resistance to daunorubicin that was significantly higher compared to de novo ANLL at diagnosis (
P<0.003). De novo ANLL at diagnosis that achieved complete remission (CR) were significantly more sensitive to daunorubicin compared to those who didn’t achieve CR (
P<0.05). There was an vitro correlation between topoisomerase II active drugs but not between these drugs and ara-C. In vitro ara-C sensitivity (≤ the median of the de novo ANLL at diagnosis) was correlated to poor overall survival (
P=0.02). In vitro sensitivity to daunorubicin and mitoxantrone was associated with prolonged disease free survival (
P=0.03 and
P=0.04). We conclude that despite significant correlation to clinical parameters for daunorubicin and mitoxantrone the predictive value of the ATP assay in this material was insufficient for directing therapy.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>10785267</pmid><doi>10.1016/S0145-2126(00)00003-5</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0145-2126 |
| ispartof | Leukemia research, 2000-05, Vol.24 (5), p.445-452 |
| issn | 0145-2126 1873-5835 |
| language | eng |
| recordid | cdi_swepub_primary_oai_swepub_ki_se_601999 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Acute Disease Adenosine Triphosphate - analysis Antibiotics, Antineoplastic - pharmacology Antibiotics, Antineoplastic - therapeutic use Biological Assay Bioluminiscence ATP assay Cell Survival Chemosensitivity Cytotoxicity Daunorubicin - pharmacology Daunorubicin - therapeutic use Drug resistance Drug Resistance, Microbial Drug Resistance, Neoplasm Humans Leukemia, Myeloid - drug therapy Leukemia, Myeloid - metabolism Leukemia, Myeloid - pathology Luminescent Measurements Myeloid leukemia Sensitivity and Specificity Tumor Cells, Cultured |
| title | In vitro chemosensitivity testing in acute non lymphocytic leukemia using the bioluminescence ATP assay |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T11%3A01%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20chemosensitivity%20testing%20in%20acute%20non%20lymphocytic%20leukemia%20using%20the%20bioluminescence%20ATP%20assay&rft.jtitle=Leukemia%20research&rft.au=M%C3%B6llg%C3%A5rd,%20Lars&rft.date=2000-05-01&rft.volume=24&rft.issue=5&rft.spage=445&rft.epage=452&rft.pages=445-452&rft.issn=0145-2126&rft.eissn=1873-5835&rft_id=info:doi/10.1016/S0145-2126(00)00003-5&rft_dat=%3Cproquest_swepu%3E71064623%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71064623&rft_id=info:pmid/10785267&rft_els_id=S0145212600000035&rfr_iscdi=true |